Clinical Trials Logo

Clinical Trial Summary

The purpose of this registry is to retrospectively and prospectively obtain clinical data in consecutively treated patients, in order to demonstrate that the commercially available Edwards SAPIEN Valve with the RF3 delivery system is a safe and effective treatment for patients with pulmonary regurgitation or stenosis.


Clinical Trial Description

Consecutive patient data should be collected at discharge, 6 months, 12 months and 2-5 years post-implant. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01356108
Study type Observational
Source Edwards Lifesciences
Contact
Status Completed
Phase
Start date January 2011
Completion date December 19, 2017

See also
  Status Clinical Trial Phase
Recruiting NCT05077774 - Harmony TPV Post-Approval Study N/A
Not yet recruiting NCT06010563 - VenusP-Valve Pivotal Study (PROTEUS STUDY) N/A
Recruiting NCT02590679 - Multi-center Trial of Percutaneous Pulmonary Valve Implantation With Venus-p Phase 2/Phase 3
Recruiting NCT05378386 - ALTERRA Post-Approval Study
Recruiting NCT04570163 - Berlin Registry of Right Heart Interventions
Active, not recruiting NCT03471936 - Right Ventricular Diastolic Function in Chronic Adverse RV Loading And Congenital Heart Disease N/A
Active, not recruiting NCT02979587 - The Medtronic Harmony™ Transcatheter Pulmonary Valve Clinical Study N/A
Completed NCT01824160 - Pulmonary Artery Repair With Covered Stents N/A
Active, not recruiting NCT03130777 - ALTERRA: SAPIEN 3 THV With the Alterra Adaptive Prestent N/A
Active, not recruiting NCT02846753 - Implantation of the Venus P-Valve™ in the Pulmonic Position in Patients With Native Outflow Tracts N/A
Completed NCT00676689 - COMPASSION - COngenital Multicenter Trial of Pulmonic VAlve Regurgitation Studying the SAPIEN InterventIONal THV N/A
Recruiting NCT04084132 - Early Versus Later Re-valving in Tetralogy of Fallot With Free Pulmonary Regurgitation N/A